Disease-specific therapy of idiopathic inflammatory demyelinating disorders.

Abstract

Central nervous system idiopathic inflammatory demyelinating disorders are a heterogenous group of diseases that share inflammation and demyelination as key features. Although the exact pathophysiology remains to be fully unveiled, these conditions are challenging to clinicians who seek specific therapeutic options for their patients. For two of these conditions, multiple sclerosis and neuromyelitis optica, there are now several possible therapies in an ever-evolving field. This review will touch on the various idiopathic inflammatory demyelinating disorders and discuss the various treatment options currently available.

DOI: 10.1586/ern.12.101

Cite this paper

@article{Khoshnam2012DiseasespecificTO, title={Disease-specific therapy of idiopathic inflammatory demyelinating disorders.}, author={Mohsen Khoshnam and Mark Steven Freedman}, journal={Expert review of neurotherapeutics}, year={2012}, volume={12 9}, pages={1113-24} }